(Q43924530)

28 November 2017

title

Lipid-lowering drugs (statins), cholesterol, and coenzyme Q10. The Baycol case--a modern Pandora's box. (English)

1 reference

28 November 2017

0 references

Bliznakov EG

1

1 reference

28 November 2017

language of work or name

1 reference

1 February 2002

1 reference

Biomedicine and Pharmacotherapy

28 November 2017

published in

1 reference

28 November 2017

volume

56

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

56-59

1 reference

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900150-0

7 January 2021

Low-density lipoprotein-independent effects of statins

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900150-0

7 January 2021

Statins and cancer: a case of meta-uncertainty

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900150-0

7 January 2021

Lotronex and the FDA: a fatal erosion of integrity

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900150-0

7 January 2021

Pleiotropic effects of statins and their clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900150-0

7 January 2021

Physicians and the pharmaceutical industry: is a gift ever just a gift?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900150-0

7 January 2021

10.1016/S0753-3322(01)00150-0

Identifiers

DOI

1 reference

28 November 2017

1 reference